Recurrent Herpes Simplex Labialis — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for recurrent herpes simplex labialis. 17 active patents protecting 2 drugs from 2+ originators. First major cliff: 2032. Daily refresh.

2
Approved drugs
17
Active US patents
72/100
Avg vulnerability
—
Annual revenue covered

Originators in Recurrent Herpes Simplex Labialis

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Merck/Upjohn) 14 patents Ligand Pharms 3 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating recurrent herpes simplex labialis. Each bar = one year. Y-axis scaled to peak year (4 patents).

2
27
1
30
4
32
4
33
4
34

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Cortef
hydrocortisone
 Generic (originally Merck/Upjohn) 14 64 — 2032-11-19
Zovirax
ACYCLOVIR
 Ligand Pharms 3 79 — 2027-03-23

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8791127 Zovirax method of use 85 2027-03-23
8747896 Zovirax method of use 80 2027-06-03
12133914 Cortef method of use 75 2043-02-23
11904046 Cortef method of use 75 2043-02-23
8592434 Zovirax method of use 73 2030-06-16
9717740 Cortef method of use 62 2032-11-19
9717740 Cortef method of use 62 2032-11-19
9717740 Cortef method of use 62 2032-11-19
9717740 Cortef method of use 62 2032-11-19
9675559 Cortef method of use 62 2033-01-10

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9649280 Cortef method of use 62 2034-05-12
9649280 Cortef method of use 62 2034-05-12
9649280 Cortef method of use 62 2034-05-12
9649280 Cortef method of use 62 2034-05-12
9675559 Cortef method of use 62 2033-01-10
9675559 Cortef method of use 62 2033-01-10
9675559 Cortef method of use 62 2033-01-10
9675559 Cortef method of use 62 2033-01-10
9717740 Cortef method of use 62 2032-11-19
9717740 Cortef method of use 62 2032-11-19

Related